Clearfield (CLFD) Earnings Analysis
Clearfield (CLFD) has no confirmed upcoming earnings date. Last quarter (2026-02-04) it beat with EPS -0.02 USD vs -0.04 USD est (+50%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E -49.88.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CLFD next report earnings?
No confirmed upcoming earnings date is currently scheduled for CLFD. This page updates as the calendar is published.
CLFD earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-04 | -0.02 USD | -0.04 USD | +50% | Beat |
| 2025-11-25 | 0.13 USD | 0.09 USD | +44.4% | Beat |
| 2025-05-08 | 0.09 USD | -0.19 USD | +147.4% | Beat |
| 2025-02-06 | -0.13 USD | -0.29 USD | +55.2% | Beat |
| 2024-11-07 | -0.06 USD | -0.19 USD | +68.4% | Beat |
| 2024-08-01 | -0.04 USD | -0.34 USD | +88.2% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
CLFD valuation and analyst view
| Trailing P/E | -49.88 |
|---|---|
| Trailing EPS | -0.63012 USD |
| Price / book | 1.73 |
| Dividend yield | 0.00% |
| Market cap | 0.42B |
| Analyst consensus | Buy (8 buy / 0 hold / 1 sell) |
| Avg price target | 44 USD |
Related research pages
Frequently asked questions
When is Clearfield (CLFD)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for CLFD. This page updates as the calendar is published.
Did CLFD beat earnings last quarter?
In its 2026-02-04 report, CLFD posted EPS of -0.02 USD versus a -0.04 USD estimate — a beat of 50%.
What is CLFD's earnings track record?
Over the last 6 reported quarters with consensus data, CLFD beat estimates 6 times (100%).
What is CLFD's current P/E ratio and EPS?
CLFD trades at a trailing P/E of -49.88 on trailing EPS of -0.6301173258856498 USD.
What do analysts rate CLFD?
Analyst consensus is "Buy" across 9 ratings (0 strong buy, 8 buy, 0 hold, 1 sell, 0 strong sell). Average 12-month price target: 44 USD.